Orlistat (Xenical) in the Treatment of Overweight Patients With Nonalcoholic Steatohepatitis (NASH)
NCT00160407
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Fatty Liver
Hepatitis
Interventions
DRUG:
Orlistat (Xenical)
BEHAVIORAL:
1400 kcal diet (30% fat)
Sponsor
St. Louis University
Collaborators
[object Object]